Myeloproliferative neoplasms include essential thrombocythemia (ET), polycythemia vera (PV), and primary myelofibrosis (PMF). These 3 diseases have common clinical features, such as a high risk of vascular complications, progression to secondary myelofibrosis, and clonal evolution into the blast phase. Current risk factors of ET and PV, used to predict events, are patient based: age >60 years and a history of thrombosis. Very recently, other parameters, such as leukocyte count and the presence of JAK2 (V617F) mutation, have been reported as potential risk factors. Prognosis in PMF is predicted at diagnosis by a combination of different risk factors, such as advanced age (age >60 years), anemia, leukocytosis (white blood cell count > 25 × 10...
Myeloproliferative neoplasms include 3 diseases: polycythemia vera (PV), essential thrombocythemia (...
Myeloproliferative neoplasms (MPNs) are currently diagnosed according to the World Health Organizati...
Diagnosis of essential thrombocythemia (ET) has been updated in the last World Health Organization (...
Myeloproliferative neoplasms include essential thrombocythemia (ET), polycythemia vera (PV), and pri...
Myeloproliferative neoplasms include essential thrombocythemia (ET), polycythemia vera (PV), and pri...
Polycythemia vera (PV) and essential thrombocythemia (ET) are myeloproliferative neoplasms with vari...
Polycythemia vera (PV) and essential thrombocythemia (ET) are myeloproliferative neoplasms with vari...
Polycythemia vera is a chronic myeloproliferative disorder affecting people in the sixth decade of l...
Myeloproliferative neoplasms include 3 diseases: polycythemia vera (PV), essential thrombocythemia (...
Myeloproliferative neoplasms include 3 diseases: polycythemia vera (PV), essential thrombocythemia (...
Myeloproliferative neoplasms (MPNs) are currently diagnosed according to the World Health Organizati...
Diagnosis of essential thrombocythemia (ET) has been updated in the last World Health Organization (...
Myeloproliferative neoplasms include essential thrombocythemia (ET), polycythemia vera (PV), and pri...
Myeloproliferative neoplasms include essential thrombocythemia (ET), polycythemia vera (PV), and pri...
Polycythemia vera (PV) and essential thrombocythemia (ET) are myeloproliferative neoplasms with vari...
Polycythemia vera (PV) and essential thrombocythemia (ET) are myeloproliferative neoplasms with vari...
Polycythemia vera is a chronic myeloproliferative disorder affecting people in the sixth decade of l...
Myeloproliferative neoplasms include 3 diseases: polycythemia vera (PV), essential thrombocythemia (...
Myeloproliferative neoplasms include 3 diseases: polycythemia vera (PV), essential thrombocythemia (...
Myeloproliferative neoplasms (MPNs) are currently diagnosed according to the World Health Organizati...
Diagnosis of essential thrombocythemia (ET) has been updated in the last World Health Organization (...